Infusion Center

We are Patient Centered.
Now serving 41 Counties in Upstate New York.

The IBD Center offers state of the art care in the Inflammatory Bowel Diseases. The Center includes:

  • An expanding concept of a Medical Home for IBD. We take responsibility for the comprehensive and complete care of the IBD patient. Our goals are to care of your infusion needs, vaccination requirements, smoking cessation, access to emotional support needs, resolution of all precertification needs, iron and anemia treatments
  • Each patient has a specialized IBD Nurse Care Manager or Navigator with whom you communicate as often as needed with direct access lines and short response times
  • The Center participates in National Quality Improvement Initiatives such as The IBD QORUS of the Crohn’s And Colitis Foundation
  • Care is delivered in a dedicated building with 8 infusion chairs, with dedicated exclusive parking and easy access
  • All endoscopic procedures are done on the same campus in a state of the art Ambulatory Endoscopy Center

Our Infusion Center Highlights

Serving NY State

We now serve 41 counties in New York State.

National Recognition

We are recognized as one of the largest community IBD centers in the Northeast.

IBD Qorus Members

We are part of the IBD Qorus. This is a national collaborative sponsored by the Crohn’s and Colitis Foundation for the improvement of quality care in the United States.

Lowest Hospitalization Rates

Our utilization of problematic drugs such as steroids and narcotics are among the lowest in the country. Our hospitalization rates and surgery rates are among the lowest in the country.

Individualized Personal Care

We believe in the concepts of shared decision making and individualized personalized care.

Nurse Care Managers

We have active nurse care managers to assist in your problems issues and health care needs.

All-Inclusive Medical Home

Our practice is developing and modeling itself on the concept of an all-inclusive medical home.
Doctor smiling while talking to a patient

Therapeutic Drugs

  • REMICADE (INFLIXIMAB) - Biologic therapy for moderate to severe Crohn’s disease or ulcerative colitis.
  • RENFLEXIS - Biosimilar therapy for moderate to severe Crohn’s disease or ulcerative colitis. Biosimilar therapy is product that is deemed highly similar to an already approved biologic (Remicade/Infliximab). These products are confirmed through various tests and clinical research.
  • INFLECTRA - Biosimilar therapy for moderate to severe Crohn’s disease or ulcerative colitis. Biosimilar therapy is product that is deemed highly similar to an already approved biologic (Remicade/Infliximab). These products are confirmed through various tests and clinical research.
  • Humira (Adilmumab) - Injection used to treat Ulcerative Colitis and Crohn’s.
  • Entyvio (VEDOLIZUMAB) - Biologic infusion for moderate to severe Crohn’s disease
  • STELARA (USTEKINUMAB) - Biologic therapy for treatment of moderate to severe Crohn’s disease.
  • Xejjanz (Tofacitinib) - Oral agent used to treat Ulcerative Colitis.
  • Skyrizi (Risankizumab) - Injection used for Crohn’s disease.
  • Rinvoq (Upadicitinib) - Oral agent used to treat Ulcerative Colitis and Crohn’s disease.
  • Zeposia (Ozanimob) - Oral agent used to treat Ulcerative Colitis